Market Cap

Nicox SA Market Capitalization:

€21.7 Million

EUR as of Jan. 1, 2024

US$24.0 Million

business Nicox SA Company Profile

Nicox SA Main Stock Listings

Market Capitalization History of Nicox SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Nicox SA market cap

Date Market Cap YoY Change
Jan. 1, 2024 €21.7 M -60.84%
Jan. 1, 2023 €55.4 M -54.16%
Jan. 1, 2022 €120.9 M -47.00%
Jan. 1, 2021 €228.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Nicox SA Categories

France languages Healthcare languages Biotechnology
France Healthcare France Biotechnology

Stocks & Indices

Nicox SA has the following listings and related stock indices.


Stock: FSX: NXOA

Stock: Euronext: COX

Stock: OTC: NICXF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.